TYRA - CIK 0001863127
Tyra Biosciences, Inc. trades as TYRA and has a market capitalization of $1.50 B, making it the #2316 largest US-listed company by market value. This page tracks Tyra Biosciences, Inc. through 396 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| SCHEDULE 13G/A | - | 2026-05-15 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| SCHEDULE 13G/A | - | 2026-05-14 |
| Quarterly report | 10-Q | 2026-05-13 |
| Major company event | 8-K | 2026-05-13 |
| Insider sale notice | 144 | 2026-05-12 |
| SCHEDULE 13G/A | - | 2026-05-12 |
| Insider trade | 4 | 2026-05-07 |
Tyra Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights | Tyra Biosciences, Inc.
Tyra Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights | Tyra Biosciences, Inc.
The largest companies sharing Tyra Biosciences, Inc.'s SEC industry classification (pharmaceutical preparations).
Tyra Biosciences, Inc. (TYRA) has a market capitalization of $1.50 B as of 2026-06-10, ranking #2316 among US-listed companies.
In its latest fiscal year Tyra Biosciences, Inc. reported a net loss of $119.95M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.